Editöre Mektup

Veno-venous ECMO in patient with COVID-19 severe pneumonia

Cilt: 42 Sayı: 1 20 Mayıs 2020
Cumhuriyet Tıp Dergisi Kapak
Cumhuriyet Tıp Dergisi
PDF İndir
EN

Veno-venous ECMO in patient with COVID-19 severe pneumonia

Abstract

Since December 2019 we have been faced with a rapidly growing number of patients with COVID-19, which is caused by the SARS-CoV-2 coronavirus. According to the Centers for Disease Control and Prevention (CDC), COVID-19 is a respiratory illness. A person may have a dry cough, fever, muscle aches, and fatigue. Most common diagnosis for severe COVID-19 is severe pneumonia which may be life threatening . In most cases, antiviral, antimicrobial, and steroidal treatment is applied in these patients. However, some cases are resistant to treatment. Then the use of extracorporeal oxygenation membranes (ECMO) may be helpful.

Keywords

Kaynakça

  1. 1. Smereka J, Szarpak L, Filipiak KJ. Modern medicine in COVID-19 era. Disaster Emerg Med J 2020; 5(2); DOI: 10.5603/DEMJ.a2020.0012 2. Dzieciatkowski T, Szarpak L, Filipiak KJ, Jaguszewski M, Ladny JR, Smereka J. COVID-19 challenge for modern medicine. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0055. 3. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924 4. Smereka J, Puslecki M, Ruetzler K, et al. Extracorporeal membrane oxygenation in COVID-19. Cardiol J. 2020 Apr 14. doi: 10.5603/CJ.a2020.0053. 5. Pravda NS, Pravda MS, Kornowski R, Orvin K. Extracorporeal membrane oxygenation therapy in the COVID-19 pandemic. Future Cardiol. 2020 Apr 17. doi: 10.2217/fca-2020-0040. 6. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020. . (accessed April 20, 2020) https://www.who.int/docs/default-source/coronaviruse/clinical-managementof-novel-cov.pdf. 7. Jacobs JP, Stammers AH, St Louis J. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J. 2020 Apr 17. doi: 10.1097/MAT.0000000000001185. 8. Burns KE, Adhikari NK, Slutsky AS, Guyatt GH, Villar J, Zhang H, Zhou Q, Cook DJ, Stewart TE, Meade MO. Pressure and volume-limited ventilation for the ventilatory management of patients with acute lung injury: a systematic review and meta-analysis. PLoS One. 2011;6:e14623. doi: 10.1371/journal.pone.0014623. 9. Luecke T, Pelosi P. Clinical review: Positive end-expiratory pressure and cardiac output. Crit Care. 2005;9:607–621. doi: 10.1186/cc3877.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Editöre Mektup

Yazarlar

Marek Dabrowski
0000-0003-1692-8578
Poland

Jacek Smereka
0000-0002-1427-4796
Poland

Anna Drozd
0000-0003-1949-4023
Poland

Yayımlanma Tarihi

20 Mayıs 2020

Gönderilme Tarihi

27 Nisan 2020

Kabul Tarihi

28 Nisan 2020

Yayımlandığı Sayı

Yıl 1970 Cilt: 42 Sayı: 1

DOI

https://doi.org/10.7197/cmj.vi.728082

IZ

https://izlik.org/JA93EJ25CT

Kaynak Göster

RIS / Bibtex
AMA
1.Dabrowski M, Smereka J, Evrin T, Katipoglu B, Drozd A, Szarpak L. Veno-venous ECMO in patient with COVID-19 severe pneumonia. CMJ. 2020;42(1):1-2. doi:10.7197/cmj.vi.728082